Compared with the control group, the NPC group had higher levels of EA-IgA (P < 0.001), Rta-IgG (P < 0.001), P85-Ab (P < 0.001) and VCA-IgA (χ2 = 262.25; P < 0.001) (Table 1). The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.